C
BMY.RT

Chescapmanager’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Chescapmanager’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,378,081
Closed -$951K – 79
2020
Q4 		$951K Buy
1,378,081
+525,000
+62% +$1.12M 0.12% 53
2020
Q3 		$1.92M Buy
853,081
+303,600
+55% +$867K 0.31% 44
2020
Q2 		$1.97M Hold
549,481
– – 0.33% 37
2020
Q1 		$2.09M Hold
549,481
– – 0.51% 29
2019
Q4 		$1.65M Buy
+549,481
New +$1.43M 0.24% 30

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $77B AUM 10.33% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Chescapmanager's BMY.RT Position: Q1 2021 in Review

Chescapmanager sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,378,081 shares — an estimated $951K sold.

Chescapmanager first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $2.09M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Chescapmanager reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Chescapmanager sold 1,378,081 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $951K.
  • Chescapmanager first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Chescapmanager's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $2.09M in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Chescapmanager's 13F filing for Q1 2021, filed 17 May 2021.